Last year’s Nobel Prize in Physiology or Medicine was awarded to John Gurdon and Shinya Yamanaka for the discovery that mature, specialized cells can be reprogrammed to be “pluripotent” stem cells, capable of becoming any type of cell in the body. That breakthrough opens numerous possibilities for regenerative therapies and for new studies of development and disease. Unfortunately, the reprogramming process, which typically involves reintroducing a handful of genes into connective skin cells called fibroblasts, has a notoriously low yield: rarely better than 1 cell in 50. And even then the induced pluripotent stem cells (iPSCs) have to be manually identified and extracted.
Andrés García and colleagues at Georgia Tech have now demonstrated a high-throughput microfluidic technique that in just a few minutes separates the iPSCs to purities approaching 99%, with a cell survival rate of 80%. The method exploits morphological changes that accompany the reprogramming. As befitting their structural...
